Mag Silver Corp (ADR) 

(Public, AMEX:MVG)   Watch this stock   
Find more results for MVG

Key stats and ratios

Q2 (Jun '09) 2008
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -19.37% -6.52%
Return on average equity -20.18% -20.42%

Address

Bentall Tower 5 Suite 328 550 Burrard Street
Vancouver, BC V6C 2B5
Canada
+1-604-6301399 (Phone)
+1-604-4844710 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance

Mag Silver Corp (ADR) discussed on blogs

Ranking 1100+ Micro Cap Stocks by Upside Potential - NASD100.com ... - Investor's Resources - NASD100.com - Daily Stock Rankings - Nov 20, 2009

Mag Silver Corp (ADR) discussions

  View all discussions »

Description

MAG Silver Corp. (MAG) is engaged in the mineral acquisition, exploration and development business. As of December 31, 2008, the Company was in the exploration-stage. The Company’s property interests are located in Mexico. MAG’s two properties include its 44% joint venture interest in the Juanicipio property and the 100% owned Cinco de Mayo property. The Company’s subsidiary, Minera Los Lagartos, S.A. DE C. V. (Lagartos) is the owner of a 44% interest in Minera Juanicipio, S.A. DE C.V. (Minera Juanicipio) and Fresnillo plc (Fresnillo).

Officers and directors

Jonathan A. Rubenstein
Chairman of the Board
Bio & Compensation - Reuters
Daniel T. MacInnis
President, Chief Executive Officer, Director
Age: 56
Bio & Compensation - Reuters
Frank R. Hallam
Chief Financial Officer
Age: 48
Bio & Compensation - Reuters
Gordon K. Neal
Vice President - Corpoarte Development
Bio & Compensation - Reuters
Jody L. Harris
Corporate Secretary
Bio & Compensation - Reuters
Eric H. Carlson
Director
Age: 50
Bio & Compensation - Reuters
R. Michael Jones
Director
Age: 43
Bio & Compensation - Reuters
Peter K.M. Megaw Ph.D.
Director
Age: 54
Bio & Compensation - Reuters
Derek C. White
Director
Age: 45
Bio & Compensation - Reuters
Richard M. Colterjohn
Director
Bio & Compensation - Reuters